64 related articles for article (PubMed ID: 20557950)
1. Neuroprotective effect of Fn14 deficiency is associated with induction of the granulocyte-colony stimulating factor (G-CSF) pathway in experimental stroke and enhanced by a pathogenic human antiphospholipid antibody.
Frauenknecht K; Bargiotas P; Bauer H; von Landenberg P; Schwaninger M; Sommer C
J Neuroimmunol; 2010 Oct; 227(1-2):1-9. PubMed ID: 20557950
[TBL] [Abstract][Full Text] [Related]
2. Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.
Sevimli S; Diederich K; Strecker JK; Schilling M; Klocke R; Nikol S; Kirsch F; Schneider A; Schäbitz WR
Exp Neurol; 2009 Jun; 217(2):328-35. PubMed ID: 19332060
[TBL] [Abstract][Full Text] [Related]
3. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).
Schäbitz WR; Krüger C; Pitzer C; Weber D; Laage R; Gassler N; Aronowski J; Mier W; Kirsch F; Dittgen T; Bach A; Sommer C; Schneider A
J Cereb Blood Flow Metab; 2008 Jan; 28(1):29-43. PubMed ID: 17457367
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
Meuer K; Pitzer C; Teismann P; Krüger C; Göricke B; Laage R; Lingor P; Peters K; Schlachetzki JC; Kobayashi K; Dietz GP; Weber D; Ferger B; Schäbitz WR; Bach A; Schulz JB; Bähr M; Schneider A; Weishaupt JH
J Neurochem; 2006 May; 97(3):675-86. PubMed ID: 16573658
[TBL] [Abstract][Full Text] [Related]
5. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis.
Schneider A; Krüger C; Steigleder T; Weber D; Pitzer C; Laage R; Aronowski J; Maurer MH; Gassler N; Mier W; Hasselblatt M; Kollmar R; Schwab S; Sommer C; Bach A; Kuhn HG; Schäbitz WR
J Clin Invest; 2005 Aug; 115(8):2083-98. PubMed ID: 16007267
[TBL] [Abstract][Full Text] [Related]
6. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice.
Komine-Kobayashi M; Zhang N; Liu M; Tanaka R; Hara H; Osaka A; Mochizuki H; Mizuno Y; Urabe T
J Cereb Blood Flow Metab; 2006 Mar; 26(3):402-13. PubMed ID: 16049425
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with granulocyte colony-stimulating factor attenuated renal ischaemia and reperfusion injury via activation of PI3/Akt signal pathway.
Li Y; Wu J; Shou Z; He Q; Zhang P; Han F; Li H; Chen J
Nephrology (Carlton); 2008 Dec; 13(6):508-16. PubMed ID: 18331437
[TBL] [Abstract][Full Text] [Related]
9. Effects of G-CSF treatment on neutrophil mobilization and neurological outcome after transient focal ischemia.
Strecker JK; Sevimli S; Schilling M; Klocke R; Nikol S; Schneider A; Schäbitz WR
Exp Neurol; 2010 Mar; 222(1):108-13. PubMed ID: 20026112
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
Chakraborty A; Guha S
Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease.
van de Geijn GJ; Aarts LH; Erkeland SJ; Prasher JM; Touw IP
Rev Physiol Biochem Pharmacol; 2003; 149():53-71. PubMed ID: 12687405
[TBL] [Abstract][Full Text] [Related]
12. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
14. The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury.
Pitzer C; Klussmann S; Krüger C; Letellier E; Plaas C; Dittgen T; Kirsch F; Stieltjes B; Weber D; Laage R; Martin-Villalba A; Schneider A
J Neurochem; 2010 May; 113(4):930-42. PubMed ID: 20202082
[TBL] [Abstract][Full Text] [Related]
15. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
[TBL] [Abstract][Full Text] [Related]
16. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice.
Tapley P; Shevde NK; Schweitzer PA; Gallina M; Christianson SW; Lin IL; Stein RB; Shultz LD; Rosen J; Lamb P
Exp Hematol; 1997 Feb; 25(2):122-31. PubMed ID: 9015212
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor has a negative effect on stroke outcome in a murine model.
Taguchi A; Wen Z; Myojin K; Yoshihara T; Nakagomi T; Nakayama D; Tanaka H; Soma T; Stern DM; Naritomi H; Matsuyama T
Eur J Neurosci; 2007 Jul; 26(1):126-33. PubMed ID: 17614944
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke.
Hasselblatt M; Jeibmann A; Riesmeier B; Maintz D; Schäbitz WR
Acta Neuropathol; 2007 Jan; 113(1):45-51. PubMed ID: 17047971
[TBL] [Abstract][Full Text] [Related]
20. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model.
Plater-Zyberk C; Joosten LA; Helsen MM; Koenders MI; Baeuerle PA; van den Berg WB
Ann Rheum Dis; 2009 May; 68(5):721-8. PubMed ID: 18495731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
